Chronic Kidney Disease-Part 1: Evaluation & Risk Assessment in CKD, Methods to Delay CKD Progression

Dana Larsen; Laalasa Varanasi; Michelle M Estrella

doi:10.1053/j.akdh.2024.07.004

Chronic Kidney Disease-Part 1: Evaluation & Risk Assessment in CKD, Methods to Delay CKD Progression

Adv Kidney Dis Health. 2024 Nov;31(6):538-545. doi: 10.1053/j.akdh.2024.07.004.

Authors

Dana Larsen¹, Laalasa Varanasi², Michelle M Estrella³

Affiliations

¹ Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA; Renal Section, Medical Service, San Francisco VA Health Care System, San Francisco, CA.
² Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
³ Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA; Renal Section, Medical Service, San Francisco VA Health Care System, San Francisco, CA; Kidney Health Research Collaborative, Department of Medicine, University of California, San Francisco and San Francisco VA Health Care System, San Francisco, CA. Electronic address: michelle.estrella@ucsf.edu.

PMID: 39577888
DOI: 10.1053/j.akdh.2024.07.004

Abstract

Chronic kidney disease (CKD) is common and leads to significant morbidity and mortality. Early detection and deployment of effective therapies could prevent CKD progression and related cardiovascular diseases. This review provides a case-based overview of key issues surrounding the diagnosis, staging, and management of CKD.

Keywords: Blood pressure; Chronic kidney disease; Diabetes.

Publication types

Review
Case Reports

MeSH terms

Disease Progression*
Early Diagnosis
Glomerular Filtration Rate
Humans
Renal Insufficiency, Chronic* / diagnosis
Risk Assessment / methods